SAMD4A
Basic information
Region (hg38): 14:54566117-54793315
Previous symbols: [ "SAMD4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SAMD4A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 1 | 1 |
Variants in SAMD4A
This is a list of pathogenic ClinVar variants found in the SAMD4A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-54568053-A-G | not specified | Uncertain significance (Jun 09, 2022) | ||
14-54568108-C-G | not specified | Uncertain significance (Aug 08, 2022) | ||
14-54568111-C-T | Benign (Feb 13, 2018) | |||
14-54702269-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
14-54702356-G-C | not specified | Uncertain significance (Dec 27, 2022) | ||
14-54702428-A-G | Uncertain significance (-) | |||
14-54702568-A-C | not specified | Uncertain significance (Jan 03, 2024) | ||
14-54737234-A-T | not specified | Uncertain significance (May 30, 2024) | ||
14-54737254-A-G | not specified | Uncertain significance (Jan 18, 2022) | ||
14-54751453-T-A | not specified | Uncertain significance (Mar 07, 2024) | ||
14-54755757-T-C | Lip and oral cavity carcinoma | association (-) | ||
14-54760222-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
14-54760243-C-T | not specified | Uncertain significance (May 17, 2023) | ||
14-54760252-C-G | not specified | Uncertain significance (Oct 10, 2023) | ||
14-54760290-C-G | not specified | Uncertain significance (Jan 07, 2022) | ||
14-54760372-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
14-54764449-T-C | Benign (Feb 13, 2018) | |||
14-54764515-T-C | not specified | Uncertain significance (Aug 17, 2022) | ||
14-54774964-G-A | Benign (Apr 10, 2018) | |||
14-54774980-G-T | not specified | Uncertain significance (Apr 20, 2024) | ||
14-54776457-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
14-54776518-C-T | Benign/Likely benign (May 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SAMD4A | protein_coding | protein_coding | ENST00000392067 | 12 | 226219 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000421 | 125733 | 0 | 15 | 125748 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.84 | 310 | 416 | 0.746 | 0.0000255 | 4650 |
Missense in Polyphen | 79 | 136.84 | 0.5773 | 1490 | ||
Synonymous | -0.420 | 175 | 168 | 1.04 | 0.0000105 | 1432 |
Loss of Function | 5.06 | 3 | 35.6 | 0.0844 | 0.00000196 | 371 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000333 | 0.0000333 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.0000652 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000805 | 0.0000791 |
Middle Eastern | 0.0000652 | 0.0000544 |
South Asian | 0.000102 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a translational repressor of SRE-containing messengers. {ECO:0000269|PubMed:16221671}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.143
- rvis_EVS
- -0.64
- rvis_percentile_EVS
- 16.63
Haploinsufficiency Scores
- pHI
- 0.899
- hipred
- Y
- hipred_score
- 0.661
- ghis
- 0.466
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.907
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Samd4
- Phenotype
- muscle phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA poly(A) tail shortening;negative regulation of translation;regulation of mRNA stability;positive regulation of translation
- Cellular component
- P-body;fibrillar center;cytosol;cell junction;dendrite;synapse
- Molecular function
- RNA binding;mRNA binding;protein binding;translation repressor activity